Fertilidad y embarazo en la mujer con esclerosis múltiple
Resumen
Bibliografía
1. Vergara F. Esclerosis múltiple y embarazo. Rev Med Chile. 2014; 142: 675-6.
2. Oldstone MBA. Molecular Mimicry: Its Evolution from Concept to Mechanism as a Cause of
Autoimmune Diseases. Monoclon Antib Immunodiagn Immunother. 2014; 33: 158-65.
3. Podbielska M, O’Keeffe J, Hogan EL. Autoimmunity in multiple sclerosis: role of sphingolipids, invariant NKT cells and other immune elements in control of inflammation and neurodegeneration. J Neurol Sci. 2018; 385: 198-214.
4. Dominguez Moreno R, Morales Esponda M, Rossiere Echazarreta NL, Olan Triano R, Gutiérrez morales JL. Esclerosis Múlti-ple: revisión de la literatura médica. Rev Fac Med Univ Nac Auton Mex. 2012; 55(5): 26-35.
5. Férnandez Férnandez Ó, Saiz A. Enfermedades desmielinizantes del sistema nervioso central. En Rozman Borstnar C, director. Farreras- Rozman: Medicina interna. 17ª ed. Barcelona: Elsevier España; 2012. p. 1353-61.
6. Mendibe MM, Boyero S, Rodrigo RM, Zarranz JJ. Esclerosis múltiple y encefalitis autoinmunes. Leucodistrofias y otras en-fermedades desmielinizantes. En Zarranz JJ, editor.
Neurología. 6ª ed. Barcelona: Elsevier España; 2013. p. 451-62.
7. Othya S, Jairamana A, Dynesa J, Donga T, Tunea C, Yeromina A et al. Regulatory T cells suppress Th17 cell Ca2+ signaling in the spinal cord during murine autoimmune neuroinflammation. PNAS. 2020; 117(33): 20088-99. Disponible en https://www.pnas.org/content/pnas/117/33/20088.full.pdf [acceso: 20/08/2020]
8. Ministerio de Sanidad, Servicios Sociales e Igualdad. Estrategia en Enfermedades Neurodegenerativas del Sistema Nacional de Salud. Ministerio de Sanidad, Servicios Sociales e Igualdad. Madrid; 2016. P. 84-102.
9. Castillo-Álvarez F, Hernando de la Bárcena I, Marzo-Sola ME. Papel de la microbiota intestinal en el desarrollo de la esclerosis múltiple. Neurología. 2018; 148: 28-32.
10. Leray E, Moreau T, Fromont A, Edan G. Epidemiology of multiple sclerosis. Rev Neurol. 2016; 172: 3-13.
11. Thompson A, Baranzini S, Geurts J, Hemmer B, Ciccarelli O. Multiple sclerosis. Lancet. 2018; 391(10130):1622-36.
12. Gagne Brosseau M, Stobbe G, Wundes A. Natalizumab-related PML 2 weeks after negative anti-JCV antibody assay. Neurol-ogy. 2016; 2; 86 (5):484-6.
13. Plavina T, Subramanyam M, Bloomgren G, Richman S, Pace A, Lee S et al. Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy. Ann Neurol. 2014; 76(6):802-12.
14. Carvalho AT, Veiga A, Morgado J, Tojal R, Rocha S, Vale J, et al. Esclerosis múltiple y decisión de la maternidad: estudio observacional en pacientes portuguesas. Rev Neurol. 2014; 59(12):537-42.
15. Langer-Gould A, Huang S, Gupta R, Leimpeter A, Greenwood E, Albers K et al. Exclusive breastfeeding and the risk of post-partum relapses in women with multiple sclerosis. Arch Neurol. 2009; 66(8): 958-63.
16. Portaccio E, Ghezzi A, Hakiki B, Martinelli V, Moiola L, Patti F et al. Breastfeeding is not related to postpartum relapses in multiple sclerosis. Neurology. 2011; 77(2): 145-50.
17. Van der Kop M, Pearce M, Dahlgren L, Synnes A, Sadovnick D, Sayao A et al. Neonatal and delivery outcomes in women with multiple sclerosis. Ann Neurol. 2011; 70(1):41-50.
18. Finkelsztejn A, Brooks J, Paschoal F, Fragoso Y. What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta-analysis of the literature. BJOG. 2011; 118(7):790-7.
19. Lu E, Wang B, Guimond C, Synnes A, Sadovnick D, Tremlett H. Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review. Neurology. 2012; 79 (11): 1130-35.
20. Correale, Farez M, Ysrraelit M. Increase in multiple sclerosis activity after asisted reproduction tecnology. Ann Neurol. 2012; 72(5):682-94.
21. Hellwig K, Haghikia A, Rockhoff M, Gold R. Multiple sclerosis and pregnancy: experience from a nationwide database in Germany. Ther Adv Neurol Disord. 2012; 5(5):247-53.
22. Michel L, Foucher Y, Vukusic S, Confavreux C, Seze J, Brassat D. Increased risk of multiple sclerosis relapse after in vitro fertilization. J Neurol Neurosurg Psychiatry. 2012; 83 (8): 796-802.
23. Ramagopalan S, Yee I, Byrnes J, Guimond C, Ebers G, Sadovnick D. Term pregnancies and the clinical characteristics of multiple sclerosis: a population based study. J Neurol Neurosurg Psychiatry. 2012; 83(8): 793-95.
24. Pasto L, Portaccio E, Ghezzi A, Hakiki B, Giannini M, Razzolini L et al. Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study. BMC Neurol. 2012; 12: 165.
25. Houtchens M, Kolb C. Multiple sclerosis and pregnancy: therapeutic considerations. J Neurol. 2013; 260 (5): 1202-14.
26. Mc Combe P, Greer J. Female reproductive issues in multiple sclerosis. Mult Scler. 2013; 19(4):392-402.
27. Coyle P. Multiple sclerosis in pregnancy. Continuum. 2014; 20:42-59.
28. Hellwing K, Rockhoff M, Herbstritt S, Borisow N, Haghikia A, Hamp E et al. Exclusive Breastfeeding and the Effect on Post-partum Multiple Sclerosis Relapses. JAMA Neurol. 2015; 72(10): 1132-38.
29. Alroughani R, Altintas A, Jumah M, Sahraian M, Alsharoqi I, Altaham A. Pregnancy and the Use of Disease-Modifying Ther-apies in Patients with Multiple Sclerosis: Benefits versus Risks. Mult Scler Int. 2016; 2016:1-8.
30. Holmoy T, Torkildsen O. Family planning, pregnancy and breastfeeding in multiple sclerosis. Tidsskr nor Laegeforen. 2016; 8; 136 (20):1726-29.
31. Almas S, Vance J, Baker T, Hale T. Management of Multiple Sclerosis in the Breastfeeding Mother. Mult Scler Int. 2016; 2016:1-11.
32. Voskuhl R, Momtazee C. Pregnancy: Effect on Multiple Sclerosis, Treatment Considerations, and Breastfeeding. Neurotherapeutics. 2017; 14 (4): 974-84.
33. Ribeiro J, Correia I, Martins A, Fonseca M, Marques I, Batista S. Pregnancy in Multiple Sclerosis: A Portuguese cohort study. Mult Scler Relat Disord. 2017; 17: 63-8.
34. Mac Donald S, McElrath T, Hernandez S. Pregnancy Outcomes in Women with Multiple Sclerosis. Am J Epidemiol. 2019; 188(1):57-66.
35. Bilbao M, Boyero S, Bárcena J, Rodriguez A. Multiple sclerosis: Pregnancy and women's health issues. Neurology. 2019; 34(4):259-69.
36. Smith A, Cohen J, Ontaneda D, Rensel M. Pregnancy and multiple sclerosis: Risk of unplanned pregnancy and drug exposure in utero. Mult Scler J Exp Transl Clin. 2019; 5(4): 1-10.
37. Coyle P, Oh J, Magyari M, Oreja C, Houtchens M. Management strategies for female patients of reproductive potential with multiple sclerosis: An evidence-based review. Mult Scler Relat Disord. 2019; 32:54-63.
- Resumen visto - 1061 veces
- PDF descargado - 66 veces
